THE WIRE · № 65405
Trinity's Next Gen Launch Report Shows Pharmaceutical Launches Deliver Strong Performance in the Face of Uncertainty
01 THE MACHINE READ
WHY IT MATTERS.
Launch success rates inform pharma revenue pipelines, but this is a vendor report with no named companies or figures tied to tickers.
Signals oncology launch strength but names no investable issuer
Named pharma launch outcomes in future reports
Vendor-sponsored data may overstate launch success
FULL DISPATCH
New research finds 51% of U.S. drug launches exceeded Wall Street revenue expectations in 2025, with oncology products leading the way WALTHAM, Mass., Oct. 5, 2026 /PRNewswire/ -- Trinity, the leader in integrating human and artificial intelligence in life sciences commercialization,...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
New Global Survey Shines a Light on the Patients Who Rely on Plasma-Derived Medicines--and the Donors Who Make Them Possible2026-10-05 15:38 UTC
Vial Doses First Patient with Asthma in Phase 1b Study of Vial's IL-13 x TSLP, a Bispecific Antibody Designed for Twice-Yearly Dosing2026-10-05 15:42 UTC
Nolla Health Announces Nation's First AI to Issue Initial Prescriptions2026-10-05 16:00 UTC
Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.2026-10-05 16:41 UTC
AHN Cardiology Department at Allegheny General Hospital Launches Clinical Trial Investigating New Therapy for Pulmonary Arterial Hypertension2026-10-05 17:45 UTC
IVD Quality Control Market to Reach US$ 2.2 Bn by 2031, Growing at 5.3% CAGR as Labs Shift to Automated QC Workflows: New Report by Wissen Research2026-10-05 18:01 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.